Egypt

BMI View: Geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Egypt looks to be a favourable strategy for any multinational... 2013-03-22

BMI View: The patent cliff has led to a flood of generic drugs into the global pharmaceutical market, resulting in downward pressure on generic drug prices and increasing competition... 2013-01-11

BMI View: Egypt's public healthcare system has traditionally targeted the country's urban population, leaving those on low incomes in remote areas with a slim chance of obtaining basic... 2012-12-14

BMI View: As anticipated by BMI, Egyptian President Mohammad Mursi's relative success in his first 100 days in office highlights a degree of political and economic stability, which... 2012-10-18

BMI View: We maintain our view that as long as political and economic instability shake Egypt, there will be no resolution of the ongoing drug pricing dispute between the government,... 2012-09-04

BMI View: The Egyptian government's implementation of an international drug-price referencing system, and its recent amendment of it, without regarding stakeholders' proposals, has... 2012-07-19

BMI View: Egypt wants to introduce hospital public-private partnerships (PPPs), which should deliver efficiency savings and better healthcare outcomes, and reduce capital outflows due... 2012-06-21